/**
 * Mechanistic Network Edges
 *
 * Causal relationships with evidence, organized by module.
 * Each edge includes citations, mechanism description, and causal confidence.
 */

import type { MechanisticEdge, RelationType } from './types';

// ============================================================================
// MODULE 1: Insulin/mTOR/Autophagy Axis
// ============================================================================

export const module1Edges: MechanisticEdge[] = [
  {
    id: 'E01.001',
    source: 'insulin_resistance',
    target: 'mTORC1_hyperactive',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'insulin_mTORC1_activation',
    mechanismDescription: 'Chronic hyperinsulinemia → sustained PI3K-AKT → TSC1/2 phosphorylation (inhibited) → Rheb-GTP accumulates → mTORC1 disinhibited on lysosomal membrane',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '15750215',
        doi: '10.3233/jad-2005-7107',
        firstAuthor: 'Steen',
        year: 2005,
        title: 'Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\'s disease--is this type 3 diabetes?',
        quote: 'Reduced levels of insulin receptor substrate (IRS) mRNA...increased glycogen synthase kinase-3beta activity',
        methodType: 'cohort',
        methodDetails: 'Human postmortem brain tissue',
        causalConfidence: 'L6',
        species: {
          ncbiTaxon: 'NCBITaxon:9606',
          commonName: 'human',
          notes: 'Postmortem AD brain tissue'
        },
      },
    ],
    translationalGap: 'Human postmortem = correlational. No human RCT. Animal interventions support directionality',
  },
  {
    id: 'E01.002',
    source: 'mTORC1_hyperactive',
    target: 'TFEB_phosphorylated',
    relation: 'directlyIncreases',
    moduleId: 'M01',
    mechanismLabel: 'mTORC1_TFEB_phosphorylation',
    mechanismDescription: 'mTORC1 directly phosphorylates TFEB at Ser211 and Ser142. pSer211 creates 14-3-3 binding site → cytoplasmic retention',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '22343943',
        doi: '10.1038/emboj.2012.32',
        firstAuthor: 'Settembre',
        year: 2012,
        title: 'A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB',
        quote: 'Phosphorylation of TFEB by mTORC1 inhibits TFEB activity. Conversely, pharmacological inhibition of mTORC1...activates TFEB by promoting its nuclear translocation',
        methodType: 'in_vitro',
        methodDetails: 'Kinase assay, HEK293/HeLa cell lines, rapamycin intervention',
        causalConfidence: 'L5',
        species: {
          ncbiTaxon: 'NCBITaxon:9606',
          commonName: 'human',
          strain: 'HEK293, HeLa'
        },
      },
    ],
    keyInsight: 'Direct biochemical + intervention reversal establishes causality',
  },
  {
    id: 'E01.003',
    source: 'TFEB_phosphorylated',
    target: 'lysosomal_genes_down',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'TFEB_cytoplasmic_sequestration',
    mechanismDescription: 'pSer211-TFEB binds 14-3-3 → cytoplasmic retention → cannot enter nucleus → CLEAR network genes not transcribed',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '22343943',
        doi: '10.1038/emboj.2012.32',
        firstAuthor: 'Settembre',
        year: 2012,
        title: 'A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB',
        quote: 'The transcriptional response of lysosomal and autophagic genes to either lysosomal dysfunction or pharmacological inhibition of mTORC1 is suppressed in TFEB-/- cells',
        methodType: 'knockout',
        methodDetails: 'TFEB-/- MEFs',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'TFEB-/- MEFs'
        },
      },
    ],
  },
  {
    id: 'E01.004',
    source: 'lysosomal_genes_down',
    target: 'lysosomal_dysfunction',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'gene_function_consequence',
    mechanismDescription: '↓v-ATPase subunits → pH rises >5.5. ↓Cathepsins → reduced proteolysis. ↓LAMP proteins → membrane instability',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '35654956',
        doi: '10.1038/s41593-022-01084-8',
        firstAuthor: 'Lee',
        year: 2022,
        title: 'Faulty autolysosome acidification in Alzheimer\'s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques',
        quote: 'Autolysosome acidification declines in neurons well before extracellular amyloid deposition, associated with markedly lowered vATPase activity',
        methodType: 'intervention_animal',
        methodDetails: 'Multiple AD mouse models (5xFAD, PS1/APP, 3xTg-AD, PS19, APPNL-G-F) with pH probes',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: '5xFAD, PS1/APP, 3xTg-AD, PS19, APPNL-G-F'
        },
      },
    ],
    quantitative: {
      foldChange: undefined,
      direction: undefined,
      confidenceInterval: undefined,
    },
    keyInsight: 'PANTHOS pattern - autolysosomes fail to acidify, becoming Aβ storage depots',
  },
  {
    id: 'E01.005',
    source: 'mTORC1_hyperactive',
    target: 'ULK1_phosphorylated',
    relation: 'directlyIncreases',
    moduleId: 'M01',
    mechanismLabel: 'mTORC1_ULK1_phosphorylation',
    mechanismDescription: 'mTORC1 phosphorylates ULK1 at Ser757, which blocks the AMPK binding site on ULK1',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '21258367',
        doi: '10.1038/ncb2152',
        firstAuthor: 'Kim',
        year: 2011,
        title: 'AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1',
        quote: 'High mTOR activity prevents Ulk1 activation by phosphorylating Ulk1 Ser 757 and disrupting the interaction between Ulk1 and AMPK',
        methodType: 'in_vitro',
        methodDetails: 'Kinase assay, phospho-specific antibody, rapamycin intervention',
        causalConfidence: 'L5',
        species: {
          ncbiTaxon: 'NCBITaxon:9606',
          commonName: 'human',
          strain: 'HEK293'
        },
      },
    ],
  },
  {
    id: 'E01.006',
    source: 'ULK1_phosphorylated',
    target: 'mitophagy_rate_reduced',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'ULK1_autophagy_block',
    mechanismDescription: 'ULK1 pSer757 blocks AMPK binding → AMPK cannot phosphorylate/activate ULK1 at Ser317/Ser777 → autophagy/mitophagy initiation blocked',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '21258367',
        doi: '10.1038/ncb2152',
        firstAuthor: 'Kim',
        year: 2011,
        title: 'AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1',
        quote: 'AMPK promotes autophagy by directly activating Ulk1 through phosphorylation of Ser 317 and Ser 777...mTOR...phosphorylating Ulk1 Ser 757 and disrupting the interaction between Ulk1 and AMPK',
        methodType: 'intervention_animal',
        methodDetails: 'Rapamycin intervention + mutant analysis',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E01.007',
    source: 'mitophagy_rate_reduced',
    target: 'damaged_mito_pool',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'mass_balance_accumulation',
    mechanismDescription: 'Damage rate exceeds clearance rate → damaged mitochondria accumulate. Stock-flow relationship',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '30742114',
        doi: '10.1038/s41593-018-0332-9',
        firstAuthor: 'Fang',
        year: 2019,
        title: 'Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer\'s disease',
        methodType: 'intervention_animal',
        methodDetails: 'Mitophagy reporters in AD models',
        causalConfidence: 'L4',
      },
      {
        pmid: '38280852',
        doi: '10.1038/s41467-024-45044-1',
        firstAuthor: 'Jimenez-Loygorri',
        year: 2024,
        title: 'Mitophagy curtails cytosolic mtDNA-induced STING signaling',
        methodType: 'intervention_animal',
        methodDetails: 'Urolithin A mitophagy induction',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'Mass balance logic: when clearance < damage rate, stock accumulates',
  },
  // S6K1-IRS1 feedback loop edges
  {
    id: 'E01.008',
    source: 'mTORC1_hyperactive',
    target: 'S6K1_active',
    relation: 'directlyIncreases',
    moduleId: 'M01',
    mechanismLabel: 'mTORC1_S6K1_phosphorylation',
    mechanismDescription: 'mTORC1 phosphorylates S6K1 at Thr389 (hydrophobic motif), enabling full activation',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '19461840',
        doi: '10.1242/jcs.051011',
        firstAuthor: 'Laplante',
        year: 2009,
        title: 'mTOR signaling at a glance',
        quote: 'mTORC1 promotes protein synthesis by phosphorylating...the p70 ribosomal S6 kinase 1 (S6K1)',
        methodType: 'review',
        methodDetails: 'Canonical mTOR signaling review',
        causalConfidence: 'L5',
      },
    ],
    keyInsight: 'S6K1-pThr389 is standard readout for mTORC1 activity',
  },
  {
    id: 'E01.009',
    source: 'S6K1_active',
    target: 'IRS1_serine_phosphorylated',
    relation: 'directlyIncreases',
    moduleId: 'M01',
    mechanismLabel: 'S6K1_IRS1_phosphorylation',
    mechanismDescription: 'S6K1 phosphorylates IRS-1 at multiple serine residues: S307, S312, S527, S616, S636/639. Creates 14-3-3 binding sites, promotes degradation',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '16914728',
        doi: '10.1128/MCB.01254-05',
        firstAuthor: 'Shah',
        year: 2006,
        title: 'Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis',
        quote: 'S6K1 phosphorylates IRS1 in vitro on multiple residues...loss- and gain-of-function S6K1 constructs...demonstrate a requirement for the catalytic activity of S6K1',
        methodType: 'in_vitro',
        methodDetails: 'Kinase assay + S6K1 gain/loss-of-function',
        causalConfidence: 'L5',
        species: {
          ncbiTaxon: 'NCBITaxon:9606',
          commonName: 'human',
          strain: 'HEK293, TSC1/2-/- MEFs'
        },
      },
    ],
    translationalGap: 'Caveat: Rajan 2013 found S6K1 inhibitor doesn\'t block pS307 in human adipocytes - may be tissue-specific',
  },
  {
    id: 'E01.010',
    source: 'IRS1_serine_phosphorylated',
    target: 'insulin_resistance',
    relation: 'increases',
    moduleId: 'M01',
    mechanismLabel: 'IRS1_insulin_signaling_block',
    mechanismDescription: 'IRS-1 serine phosphorylation: (1) reduces tyrosine phosphorylation by insulin receptor, (2) promotes IRS-1 degradation, (3) creates 14-3-3 binding → sequestration',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '28550243',
        doi: '10.3233/JAD-160344',
        firstAuthor: 'Nakamura',
        year: 2017,
        title: 'Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer\'s Disease',
        quote: 'Protein levels of pS616 and pS636/639 IRS-1 significantly decreased following APO treatment...suggesting improved brain insulin resistance',
        methodType: 'intervention_animal',
        methodDetails: 'Apomorphine treatment in 3xTg-AD mice',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: '3xTg-AD'
        },
      },
      {
        pmid: '30463045',
        doi: '10.1016/j.biopha.2018.11.043',
        firstAuthor: 'Rahman',
        year: 2018,
        title: 'Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer\'s disease',
        quote: 'Aβ(1-42) ICV injection → elevated IRS-S307 in hippocampus; astaxanthin reverses',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10116',
          commonName: 'rat',
          strain: 'Wistar'
        },
      },
    ],
    keyInsight: 'This edge closes the feedback loop: mTORC1→S6K1→IRS1→insulin_resistance→mTORC1',
  },
];

// ============================================================================
// MODULE 2: Lysosomal Pathology
// ============================================================================

export const module2Edges: MechanisticEdge[] = [
  // Route 1A: LMP Pathway
  {
    id: 'E02.001',
    source: 'lysosomal_dysfunction',
    target: 'cargo_accumulation',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'degradation_failure_accumulation',
    mechanismDescription: 'Reduced degradation capacity (↓cathepsins, ↓v-ATPase, high pH) → cargo builds up. Stock-flow: inflow unchanged, outflow reduced',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '35654956',
        doi: '10.1038/s41593-022-01084-8',
        firstAuthor: 'Lee',
        year: 2022,
        title: 'Faulty autolysosome acidification in Alzheimer\'s disease mouse models...',
        quote: 'Build-up of Aβ/APP-βCTF selectively within enlarged de-acidified autolysosomes',
        methodType: 'intervention_animal',
        methodDetails: 'AD mouse models with autophagy reporters',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: '5xFAD, PS1/APP, 3xTg-AD, PS19, APPNL-G-F'
        },
      },
    ],
  },
  {
    id: 'E02.002',
    source: 'cargo_accumulation',
    target: 'lipofuscin',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'oxidative_crosslinking',
    mechanismDescription: 'Incomplete degradation of proteins/lipids → oxidation → cross-linking → lipofuscin granules (irreversible)',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '34782457',
        doi: '10.1073/pnas.2100122118',
        firstAuthor: 'Pan',
        year: 2021,
        title: 'Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization',
        quote: 'Lipofuscin granules enclose mixtures of cross-linked proteins and lipids',
        methodType: 'intervention_animal',
        methodDetails: 'Aged mice, RPE cells',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'Abca4-/- mice'
        },
      },
    ],
    keyInsight: 'Lipofuscin formation is IRREVERSIBLE - no known degradation pathway',
  },
  {
    id: 'E02.003',
    source: 'lipofuscin',
    target: 'LMP',
    relation: 'directlyIncreases',
    moduleId: 'M02',
    mechanismLabel: 'lipofuscin_membrane_damage',
    mechanismDescription: 'Lipofuscin directly destabilizes lysosomal membrane through physical/oxidative damage → permeabilization',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '34782457',
        doi: '10.1073/pnas.2100122118',
        firstAuthor: 'Pan',
        year: 2021,
        title: 'Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization',
        quote: 'Tendency to cause lysosome swelling that results in rupture...ability to trigger NLRP3 inflammation, a symptom of low-level disruption of lysosomes',
        methodType: 'intervention_animal',
        methodDetails: 'In vitro RPE cells + aged mice',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'Abca4-/- mice'
        },
      },
    ],
    keyInsight: 'Also triggers atypical necroptosis (RIPK1/RIPK3/MLKL independent)',
  },
  {
    id: 'E02.004',
    source: 'LMP',
    target: 'cathepsin_B_cytosolic',
    relation: 'directlyIncreases',
    moduleId: 'M02',
    mechanismLabel: 'compartment_breach',
    mechanismDescription: 'Lysosomal membrane permeabilization → cathepsins (including active cathepsin B) leak into cytosol',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '23720375',
        doi: '10.1242/jcs.091181',
        firstAuthor: 'Aits',
        year: 2013,
        title: 'Lysosomal cell death at a glance',
        quote: 'Lysosomal membrane permeabilization and the consequent leakage of the lysosomal content into the cytosol leads to "lysosomal cell death"',
        methodType: 'in_vitro',
        methodDetails: 'Multiple cell types',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E02.005',
    source: 'cathepsin_B_cytosolic',
    target: 'NLRP3_active',
    relation: 'directlyIncreases',
    moduleId: 'M02',
    mechanismLabel: 'cathepsin_NLRP3_activation',
    mechanismDescription: 'Cytosolic cathepsin B promotes NLRP3-ASC complex assembly',
    causalConfidence: 'L5',
    crossModule: 'Output to Module 4 (Inflammasome)',
    evidence: [
      {
        pmid: '18604214',
        doi: '10.1038/ni.1631',
        firstAuthor: 'Hornung',
        year: 2008,
        title: 'Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization',
        quote: 'Inhibition of...cathepsin B activity impaired NALP3 activation',
        methodType: 'knockout',
        methodDetails: 'Cathepsin B-/- mice; CA-074-Me inhibitor',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'Ctsb-/-'
        },
      },
    ],
    keyInsight: 'Establishes LMP → cathepsin B → NLRP3 as general danger-sensing mechanism',
  },

  // Route 1B: Incomplete Mitophagy Pathway
  {
    id: 'E02.006',
    source: 'damaged_mito_pool',
    target: 'mitophagosome',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'PINK1_Parkin_mitophagy_initiation',
    mechanismDescription: 'PINK1 stabilizes on depolarized mitochondria → Parkin recruited → ubiquitin chains → autophagy receptors → autophagosome formation',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '18227278',
        firstAuthor: 'Narendra',
        year: 2008,
        title: 'Parkin is recruited selectively to impaired mitochondria and promotes their autophagy',
        methodType: 'knockout',
        methodDetails: 'PINK1-/-, Parkin-/- studies',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'This step works normally in AD; the problem is downstream degradation',
  },
  {
    id: 'E02.007',
    source: 'mitophagosome',
    target: 'autolysosome',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'autophagosome_lysosome_fusion',
    mechanismDescription: 'Autophagosome fuses with lysosome via SNARE proteins (STX17, SNAP29, VAMP8)',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '31682838',
        doi: '10.1016/j.jmb.2019.10.024',
        firstAuthor: 'Zhao',
        year: 2020,
        title: 'Autophagosome-Lysosome Fusion',
        quote: 'autophagosome-lysosome fusion to generate autolysosomes that degrade the cargo',
        methodType: 'review',
        methodDetails: 'Comprehensive review of SNARE-mediated fusion mechanisms',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E02.008',
    source: 'lysosomal_dysfunction',
    target: 'mtDNA_undegraded',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'DNase_II_pH_failure',
    mechanismDescription: 'DNase II requires pH <5 for activity. Lysosomal pH >5.5 → DNase II inactive → mtDNA persists undegraded in autolysosome',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '22535248',
        doi: '10.1038/nature10992',
        firstAuthor: 'Oka',
        year: 2012,
        title: 'Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure',
        quote: 'Cardiac-specific deletion of lysosomal deoxyribonuclease (DNase) II...caused severe myocarditis and dilated cardiomyopathy...with accumulation of mitochondrial DNA deposits in autolysosomes',
        methodType: 'knockout',
        methodDetails: 'Dnase2a cardiac-specific KO',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'Dnase2a cardiac-specific KO'
        },
      },
    ],
    keyInsight: 'LANDMARK PAPER - established mtDNA escape as inflammatory trigger',
  },
  {
    id: 'E02.009',
    source: 'mtDNA_undegraded',
    target: 'mtDNA_from_lysosome',
    relation: 'increases',
    moduleId: 'M02',
    mechanismLabel: 'mtDNA_lysosomal_escape',
    mechanismDescription: 'Undegraded mtDNA exits through compromised autolysosomal membrane (LMP affects autolysosomes too)',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '22535248',
        doi: '10.1038/nature10992',
        firstAuthor: 'Oka',
        year: 2012,
        title: 'Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E02.010',
    source: 'mtDNA_from_lysosome',
    target: 'cGAS_active',
    relation: 'directlyIncreases',
    moduleId: 'M02',
    mechanismLabel: 'mtDNA_cGAS_sensing',
    mechanismDescription: 'Cytosolic mtDNA (CpG-rich, bacterial-like) sensed by cGAS → 2\'3\'-cGAMP → STING → TBK1 → IRF3 → Type I IFN',
    causalConfidence: 'L3',
    crossModule: 'Output to Module 4 (Inflammasome)',
    evidence: [
      {
        pmid: '37532932',
        doi: '10.1038/s41586-023-06373-1',
        firstAuthor: 'Gulen',
        year: 2023,
        title: 'cGAS-STING drives ageing-related inflammation and neurodegeneration',
        quote: 'Cytosolic DNA released from perturbed mitochondria elicits cGAS activity in old microglia',
        methodType: 'knockout',
        methodDetails: 'STING knockout + cGAS gain-of-function knockin',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
        },
      },
    ],
    keyInsight: 'Brain-specific: STING activation triggers reactive microglial transcriptional states',
  },
];

// ============================================================================
// MODULE 3: Mitochondrial Dysfunction (Route 2)
// ============================================================================

export const module3Edges: MechanisticEdge[] = [
  {
    id: 'E03.001',
    source: 'damaged_mito_pool',
    target: 'mito_ROS',
    relation: 'increases',
    moduleId: 'M03',
    mechanismLabel: 'ETC_dysfunction_ROS',
    mechanismDescription: 'Damaged mitochondria have dysfunctional ETC → electron leak at Complex I/III → superoxide production',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '30742114',
        doi: '10.1038/s41593-018-0332-9',
        firstAuthor: 'Fang',
        year: 2019,
        title: 'Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer\'s disease',
        quote: 'Mitochondrial dysfunction and accumulation of damaged mitochondria are common features of aging and age-related neurodegeneration',
        methodType: 'intervention_animal',
        methodDetails: 'AD mouse models with NAD+ precursor intervention',
        causalConfidence: 'L4',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: 'APP/PS1, 3xTgAD'
        },
      },
    ],
  },
  {
    id: 'E03.002',
    source: 'mito_ROS',
    target: 'mtDNA_oxidized',
    relation: 'directlyIncreases',
    moduleId: 'M03',
    mechanismLabel: 'ROS_DNA_oxidation',
    mechanismDescription: 'ROS oxidizes guanine bases in mtDNA → 8-oxo-deoxyguanosine. mtDNA vulnerable due to proximity to ETC and lack of histones',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling',
        quote: 'ROS...induce Ox-mtDNA generation',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E03.003',
    source: 'mito_ROS',
    target: 'Ca_overload',
    relation: 'increases',
    moduleId: 'M03',
    mechanismLabel: 'ROS_calcium_dysregulation',
    mechanismDescription: 'ROS damages Ca²⁺ handling proteins (MCU, NCLX) → impaired Ca²⁺ efflux + sustained MCU-mediated uptake → matrix Ca²⁺ accumulation',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'ROS impairs Ca²⁺ handling, MCU-mediated uptake',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E03.004',
    source: 'Ca_overload',
    target: 'mPTP_open',
    relation: 'directlyIncreases',
    moduleId: 'M03',
    mechanismLabel: 'calcium_mPTP_trigger',
    mechanismDescription: 'Ca²⁺ binds to mPTP regulatory site (likely CypD) → conformational change → pore opening in inner mitochondrial membrane',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'Diverse NLRP3 inflammasome activators rapidly stimulated uniporter-mediated calcium uptake to open mitochondrial permeability transition pores (mPTP)',
        methodType: 'in_vitro',
        methodDetails: 'Isolated mitochondria + interventions',
        causalConfidence: 'L5',
      },
    ],
    keyInsight: 'Ca²⁺ is the canonical trigger for mPTP; CsA (CypD inhibitor) blocks it',
  },
  {
    id: 'E03.005',
    source: 'mPTP_open',
    target: 'VDAC_oligomer',
    relation: 'increases',
    moduleId: 'M03',
    mechanismLabel: 'mPTP_VDAC_coordination',
    mechanismDescription: 'mPTP opening causes inner membrane stress + mtDNA interaction with VDAC → triggers VDAC oligomerization in outer membrane',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'trigger VDAC oligomerization. This occurred independently of mtDNA or reactive oxygen species',
        methodType: 'intervention_animal',
        methodDetails: 'mPTP inhibitors reduce VDAC oligomerization',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'mPTP and VDAC coordinate but are mechanistically independent of mtDNA/ROS per se',
  },
  {
    id: 'E03.006',
    source: 'mtDNA_oxidized',
    target: 'ox_mtDNA_cytosolic',
    relation: 'increases',
    moduleId: 'M03',
    mechanismLabel: 'FEN1_cleavage_release',
    mechanismDescription: 'FEN1 endonuclease cleaves ox-mtDNA into 500-650 bp fragments; these fragments exit via mPTP/VDAC pores',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'Within mitochondria, Ox-mtDNA was either repaired by DNA glycosylase OGG1 or cleaved by the endonuclease FEN1 to 500-650 bp fragments that exited mitochondria',
        methodType: 'knockout',
        methodDetails: 'FEN1 inhibitor studies',
        causalConfidence: 'L3',
      },
    ],
    therapeuticImplication: 'FEN1 inhibitors suppress IL-1β production and mtDNA release in mice',
  },
  {
    id: 'E03.007',
    source: 'VDAC_oligomer',
    target: 'ox_mtDNA_cytosolic',
    relation: 'directlyIncreases',
    moduleId: 'M03',
    mechanismLabel: 'VDAC_pore_transport',
    mechanismDescription: 'VDAC oligomers form large pores in outer membrane → allow 500-650 bp ox-mtDNA fragments to exit',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'exited mitochondria via mPTP- and VDAC-dependent channels',
        methodType: 'in_vitro',
        methodDetails: 'VDAC inhibitors (VBIT-4) reduce mtDNA release',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E03.008',
    source: 'ox_mtDNA_cytosolic',
    target: 'NLRP3_active',
    relation: 'directlyIncreases',
    moduleId: 'M03',
    mechanismLabel: 'ox_mtDNA_NLRP3_binding',
    mechanismDescription: 'Oxidized mtDNA (8-oxo-dG containing) specifically binds NLRP3 LRR domain and triggers inflammasome assembly. Non-oxidized mtDNA does NOT activate NLRP3',
    causalConfidence: 'L5',
    crossModule: 'Output to Module 4 (Inflammasome)',
    evidence: [
      {
        pmid: '35835107',
        doi: '10.1016/j.immuni.2022.06.007',
        firstAuthor: 'Xian',
        year: 2022,
        title: 'Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels...',
        quote: 'Ox-mtDNA...binds cytosolic NLRP3, thereby triggering inflammasome activation',
        methodType: 'knockout',
        methodDetails: 'OGG1-/- enhances, FEN1-KO abolishes NLRP3 activation',
        causalConfidence: 'L5',
      },
    ],
    keyInsight: 'CRITICAL: Oxidation state is the molecular switch - ox-mtDNA→NLRP3, non-ox-mtDNA→cGAS',
  },
  {
    id: 'E03.009',
    source: 'mtDNA_cytosolic',
    target: 'cGAS_active',
    relation: 'directlyIncreases',
    moduleId: 'M03',
    mechanismLabel: 'mtDNA_cGAS_sensing',
    mechanismDescription: 'Cytosolic dsDNA (including non-oxidized mtDNA) is sensed by cGAS → 2\'3\'-cGAMP → STING → TBK1 → IRF3 → Type I IFN',
    causalConfidence: 'L3',
    crossModule: 'Output to Module 4 (Inflammasome)',
    evidence: [
      {
        pmid: '37532932',
        doi: '10.1038/s41586-023-06373-1',
        firstAuthor: 'Gulen',
        year: 2023,
        title: 'cGAS-STING drives ageing-related inflammation and neurodegeneration',
        methodType: 'knockout',
        methodDetails: 'cGAS-/-, STING-/- knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  // Protective edge
  {
    id: 'E03.010',
    source: 'PINK1_Parkin',
    target: 'mtDNA_cytosolic',
    relation: 'decreases',
    moduleId: 'M03',
    mechanismLabel: 'mitophagy_prevents_mtDNA_release',
    mechanismDescription: 'Functional PINK1/Parkin mitophagy clears damaged mitochondria BEFORE mtDNA can escape → prevents mtDNA release',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '33029617',
        doi: '10.1093/brain/awaa246',
        firstAuthor: 'Borsche',
        year: 2020,
        title: 'Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism',
        quote: 'elevated IL6 levels in patients with biallelic PRKN/PINK1 mutations...increased circulating cell-free mtDNA serum levels',
        methodType: 'cohort',
        methodDetails: 'Human PRKN/PINK1 carriers',
        causalConfidence: 'L6',
        species: {
          ncbiTaxon: 'NCBITaxon:9606',
          commonName: 'human',
          notes: 'Biallelic PRKN/PINK1 mutation carriers'
        },
      },
      {
        pmid: '38280852',
        doi: '10.1038/s41467-024-45044-1',
        firstAuthor: 'Jimenez-Loygorri',
        year: 2024,
        title: 'Mitophagy curtails cytosolic mtDNA-induced STING signaling',
        quote: 'pharmacological induction of mitophagy with urolithin A attenuates cGAS/STING activation',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'PINK1/Parkin are gatekeepers preventing inflammatory mtDNA release',
    translationalGap: 'Note: Original Sliter 2018 source RETRACTED July 2025; mechanism validated by independent sources',
  },
];

// ============================================================================
// MODULE 4: Inflammasome & Cytokines
// ============================================================================

export const module4Edges: MechanisticEdge[] = [
  {
    id: 'E04.001',
    source: 'NLRP3_active',
    target: 'caspase1_active',
    relation: 'directlyIncreases',
    moduleId: 'M04',
    mechanismLabel: 'inflammasome_caspase1_recruitment',
    mechanismDescription: 'NLRP3 recruits ASC → ASC oligomerizes → recruits pro-caspase-1 → caspase-1 auto-activates',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '23254930',
        doi: '10.1038/nature11729',
        firstAuthor: 'Heneka',
        year: 2013,
        title: 'NLRP3 is activated in Alzheimer\'s disease and contributes to pathology in APP/PS1 mice',
        quote: 'Nlrp3(-/-) or Casp1(-/-) mice...demonstrated reduced brain caspase-1 and interleukin-1β activation',
        methodType: 'knockout',
        methodDetails: 'NLRP3-/- and Caspase-1-/- crossed with APP/PS1',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: 'APP/PS1; Nlrp3-/-; Casp1-/-'
        },
      },
    ],
    keyInsight: 'LANDMARK PAPER - First demonstration that NLRP3-/- protects from AD pathology',
  },
  {
    id: 'E04.002',
    source: 'caspase1_active',
    target: 'IL1B',
    relation: 'directlyIncreases',
    moduleId: 'M04',
    mechanismLabel: 'IL1B_cleavage',
    mechanismDescription: 'Caspase-1 cleaves pro-IL-1β (31 kDa) to mature IL-1β (17 kDa)',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '31036653',
        doi: '10.3390/ijms20112611',
        firstAuthor: 'Swanson',
        year: 2019,
        title: 'The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation',
        quote: 'The NLRP3 inflammasome is a critical component of the innate immune system that mediates caspase-1 activation and the secretion of proinflammatory cytokines IL-1β/IL-18',
        methodType: 'review',
        methodDetails: 'Comprehensive review of NLRP3/caspase-1/IL-1β axis',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E04.003',
    source: 'cGAS_active',
    target: 'STING_active',
    relation: 'directlyIncreases',
    moduleId: 'M04',
    mechanismLabel: 'cGAMP_STING_activation',
    mechanismDescription: 'cGAS produces 2\'3\'-cGAMP → binds STING → STING translocates to Golgi → phosphorylated',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '37532932',
        doi: '10.1038/s41586-023-06373-1',
        firstAuthor: 'Gulen',
        year: 2023,
        title: 'cGAS-STING drives ageing-related inflammation and neurodegeneration',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E04.004',
    source: 'STING_active',
    target: 'type_I_IFN',
    relation: 'increases',
    moduleId: 'M04',
    mechanismLabel: 'STING_IFN_induction',
    mechanismDescription: 'STING → TBK1 → IRF3 phosphorylation → IRF3 dimerization → nuclear translocation → IFN-α/β transcription',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '37532932',
        doi: '10.1038/s41586-023-06373-1',
        firstAuthor: 'Gulen',
        year: 2023,
        title: 'cGAS-STING drives ageing-related inflammation and neurodegeneration',
        quote: 'Blockade of STING suppresses the inflammatory phenotypes of senescent human cells and tissues',
        methodType: 'knockout',
        methodDetails: 'STING-/- abolishes IFN response',
        causalConfidence: 'L3',
      },
    ],
  },
  // NLRP3 → tau hyperphosphorylation pathway
  {
    id: 'E04.005',
    source: 'NLRP3_active',
    target: 'GSK3B_active',
    relation: 'increases',
    moduleId: 'M04',
    mechanismLabel: 'NLRP3_GSK3B_activation',
    mechanismDescription: 'NLRP3 signaling activates GSK-3β (tau kinase)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '31748742',
        doi: '10.1038/s41586-019-1769-z',
        firstAuthor: 'Ising',
        year: 2019,
        title: 'NLRP3 inflammasome activation drives tau pathology',
        quote: 'Loss of NLRP3 inflammasome function reduced tau hyperphosphorylation and aggregation by regulating tau kinases and phosphatases',
        methodType: 'knockout',
        methodDetails: 'Nlrp3-/- in Tau22 and injection models',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          model: 'Tau22, injection models'
        },
      },
    ],
    keyInsight: 'LANDMARK PAPER - NLRP3 → tau hyperphosphorylation',
  },
  {
    id: 'E04.006',
    source: 'NLRP3_active',
    target: 'PP2A_activity',
    relation: 'decreases',
    moduleId: 'M04',
    mechanismLabel: 'NLRP3_PP2A_inhibition',
    mechanismDescription: 'NLRP3 signaling inhibits PP2A (major tau phosphatase)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '31748742',
        doi: '10.1038/s41586-019-1769-z',
        firstAuthor: 'Ising',
        year: 2019,
        title: 'NLRP3 inflammasome activation drives tau pathology',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E04.007',
    source: 'GSK3B_active',
    target: 'tau_hyperphosphorylated',
    relation: 'directlyIncreases',
    moduleId: 'M04',
    mechanismLabel: 'GSK3B_tau_phosphorylation',
    mechanismDescription: 'GSK-3β phosphorylates tau at multiple pathological sites: pSer199, pSer202/Thr205 (AT8), pThr231, pSer396/Ser404 (PHF-1)',
    causalConfidence: 'L5',
    crossModule: 'Output to Module 7 (Tau)',
    evidence: [
      {
        pmid: '26631930',
        doi: '10.1038/nrn.2015.1',
        firstAuthor: 'Wang',
        year: 2016,
        title: 'Tau in physiology and pathology',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E04.008',
    source: 'PP2A_activity',
    target: 'tau_hyperphosphorylated',
    relation: 'decreases',
    moduleId: 'M04',
    mechanismLabel: 'PP2A_tau_dephosphorylation',
    mechanismDescription: 'PP2A is the major tau phosphatase; reduced activity → phospho-tau accumulates',
    causalConfidence: 'L5',
    crossModule: 'Output to Module 7 (Tau)',
    evidence: [
      {
        pmid: '26631930',
        doi: '10.1038/nrn.2015.1',
        firstAuthor: 'Wang',
        year: 2016,
        title: 'Tau in physiology and pathology',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  // Feedback loops (Aβ and tau → NLRP3)
  {
    id: 'E04.009',
    source: 'Abeta_oligomers',
    target: 'NLRP3_active',
    relation: 'increases',
    moduleId: 'M04',
    mechanismLabel: 'Abeta_NLRP3_activation',
    mechanismDescription: 'Aβ oligomers are phagocytosed by microglia → lysosomal rupture → NLRP3 activation',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 6 (Amyloid)',
    evidence: [
      {
        pmid: '23254930',
        doi: '10.1038/nature11729',
        firstAuthor: 'Heneka',
        year: 2013,
        title: 'NLRP3 is activated in Alzheimer\'s disease and contributes to pathology in APP/PS1 mice',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E04.010',
    source: 'tau_aggregated',
    target: 'NLRP3_active',
    relation: 'increases',
    moduleId: 'M04',
    mechanismLabel: 'tau_NLRP3_activation',
    mechanismDescription: 'Tau aggregates also activate NLRP3 (creates feedforward loop)',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 7 (Tau) - creates feedback loop',
    isGhost: true,
    completesLoop: 'loop_NLRP3_tau_feedforward',
    evidence: [
      {
        pmid: '31748742',
        doi: '10.1038/s41586-019-1769-z',
        firstAuthor: 'Ising',
        year: 2019,
        title: 'NLRP3 inflammasome activation drives tau pathology',
        quote: 'Tau activated the NLRP3 inflammasome',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'Creates self-amplifying tau pathology loop',
  },
];

// ============================================================================
// MODULE 5: Microglial Phenotypes
// ============================================================================

export const module5Edges: MechanisticEdge[] = [
  {
    id: 'E05.001',
    source: 'neuroinflammation',
    target: 'microglia_activated',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'inflammation_microglia_activation',
    mechanismDescription: 'Cytokines and DAMPs activate microglia from homeostatic state',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '33318676',
        doi: '10.1038/s41582-020-00435-y',
        firstAuthor: 'Leng',
        year: 2021,
        title: 'Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?',
        quote: 'the discovery of increased inflammatory markers in AD patients and identification of AD risk genes associated with innate immune functions suggest neuroinflammation has a prominent role in AD pathogenesis',
        methodType: 'review',
        methodDetails: 'Nature Reviews Neurology comprehensive review',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E05.002',
    source: 'microglia_activated',
    target: 'NF_kB_active',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'activation_NFkB',
    mechanismDescription: 'Microglial activation triggers NF-κB nuclear translocation',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '36875627',
        doi: '10.3389/fimmu.2023.1117172',
        firstAuthor: 'Wang',
        year: 2023,
        title: 'The effects of microglia-associated neuroinflammation on Alzheimer\'s disease',
        quote: 'NF-κB activation stimulates BACE1 expression and Aβ processing',
        methodType: 'review',
        methodDetails: 'Frontiers in Immunology comprehensive review',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E05.003',
    source: 'NF_kB_active',
    target: 'HIF1A_stabilized',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'NFkB_HIF1A_stabilization',
    mechanismDescription: 'NF-κB signaling stabilizes HIF-1α under normoxia',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '27801979',
        doi: '10.1016/j.cmet.2016.10.007',
        firstAuthor: 'Tannahill',
        year: 2016,
        title: 'HIF1α and metabolic reprogramming in inflammation',
        quote: 'succinate buildup...competitive inhibition of Prolyl Hydroxylase Domain (PHD) enzymes...stabilization of HIF-1α',
        methodType: 'review',
        methodDetails: 'Cell Metabolism review on inflammatory metabolic reprogramming',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E05.004',
    source: 'HIF1A_stabilized',
    target: 'glycolytic_switch',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'HIF1A_glycolysis',
    mechanismDescription: 'HIF-1α → PKM2 dimer → aerobic glycolysis (Warburg effect)',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '39302180',
        doi: '10.3390/cells13181535',
        firstAuthor: 'Gopalkrishna',
        year: 2024,
        title: 'Microglial Metabolic Reprogramming: Emerging Insights and Therapeutic Strategies in Neurodegenerative Diseases',
        quote: 'activation of mTOR triggers the expression of HIF1α...heightened activity of crucial glycolytic enzymes, including GLUT1, HK2, and PDK1',
        methodType: 'review',
        methodDetails: 'Comprehensive review on microglial metabolic reprogramming',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E05.005',
    source: 'glycolytic_switch',
    target: 'SREBP1_active',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'glycolysis_SREBP1',
    mechanismDescription: 'Glycolytic intermediates activate SREBP1 lipogenic program',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '31959936',
        doi: '10.1038/s41593-019-0566-1',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E05.006',
    source: 'SREBP1_active',
    target: 'lipid_droplets',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'SREBP1_lipogenesis',
    mechanismDescription: 'SREBP1 drives lipid synthesis → lipid droplet formation',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '31959936',
        doi: '10.1038/s41593-019-0566-1',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E05.007',
    source: 'lipid_droplets',
    target: 'LDAM',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'LD_LDAM_phenotype',
    mechanismDescription: 'Lipid droplet accumulation defines LDAM phenotype',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '31959936',
        doi: '10.1038/s41593-019-0566-1',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain',
        quote: 'LDAM...are defective in phagocytosis, produce high levels of reactive oxygen species and secrete proinflammatory cytokines',
        methodType: 'in_vitro',
        methodDetails: 'scRNA-seq + functional assays + CRISPR screen',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'LANDMARK PAPER - Discovery of LDAM phenotype',
  },
  {
    id: 'E05.008',
    source: 'LDAM',
    target: 'phagocytosis_impaired',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'LDAM_phagocytosis_failure',
    mechanismDescription: 'LDAM phenotype characterized by defective phagocytosis',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '31959936',
        doi: '10.1038/s41593-019-0566-1',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain',
        quote: 'LDAM...are defective in phagocytosis',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
    therapeuticImplication: 'DGAT2 inhibitors may restore microglial function',
  },
  {
    id: 'E05.009',
    source: 'LDAM',
    target: 'C1q',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'LDAM_C1q_production',
    mechanismDescription: 'LDAM microglia produce C1q',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 8 (Complement)',
    evidence: [
      {
        pmid: '31959936',
        doi: '10.1038/s41593-019-0566-1',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  // A1 astrocyte induction
  {
    id: 'E05.010',
    source: 'microglia_activated',
    target: 'IL1A',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'microglia_IL1A',
    mechanismDescription: 'Activated microglia produce IL-1α',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28099414',
        doi: '10.1038/nature21029',
        firstAuthor: 'Liddelow',
        year: 2017,
        title: 'Neurotoxic reactive astrocytes are induced by activated microglia',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E05.011',
    source: 'microglia_activated',
    target: 'TNF',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'microglia_TNF',
    mechanismDescription: 'Activated microglia produce TNF-α',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28099414',
        doi: '10.1038/nature21029',
        firstAuthor: 'Liddelow',
        year: 2017,
        title: 'Neurotoxic reactive astrocytes are induced by activated microglia',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E05.012',
    source: 'IL1A',
    target: 'A1_astrocytes',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'IL1A_A1_induction',
    mechanismDescription: 'IL-1α required for A1 astrocyte induction (with TNF + C1q)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28099414',
        doi: '10.1038/nature21029',
        firstAuthor: 'Liddelow',
        year: 2017,
        title: 'Neurotoxic reactive astrocytes are induced by activated microglia',
        quote: 'Activated microglia induce A1 astrocytes by secreting Il-1α, TNF and C1q',
        methodType: 'knockout',
        methodDetails: 'Triple knockout (Il1a-/-;Tnf-/-;C1qa-/-)',
        causalConfidence: 'L3',
        species: {
          ncbiTaxon: 'NCBITaxon:10090',
          commonName: 'mouse',
          strain: 'Il1a-/-;Tnf-/-;C1qa-/-'
        },
      },
    ],
    keyInsight: 'LANDMARK PAPER - IL-1α + TNF + C1q are NECESSARY and SUFFICIENT for A1 induction',
  },
  {
    id: 'E05.013',
    source: 'TNF',
    target: 'A1_astrocytes',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'TNF_A1_induction',
    mechanismDescription: 'TNF required for A1 astrocyte induction (with IL-1α + C1q)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28099414',
        doi: '10.1038/nature21029',
        firstAuthor: 'Liddelow',
        year: 2017,
        title: 'Neurotoxic reactive astrocytes are induced by activated microglia',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E05.014',
    source: 'C1q',
    target: 'A1_astrocytes',
    relation: 'increases',
    moduleId: 'M05',
    mechanismLabel: 'C1q_A1_induction',
    mechanismDescription: 'C1q required for A1 astrocyte induction (with IL-1α + TNF)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28099414',
        doi: '10.1038/nature21029',
        firstAuthor: 'Liddelow',
        year: 2017,
        title: 'Neurotoxic reactive astrocytes are induced by activated microglia',
        quote: 'A1 astrocytes lose the ability to promote neuronal survival...and induce the death of neurons and oligodendrocytes',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'A1 astrocytes abundant in AD, PD, HD, ALS, MS',
  },
];

// ============================================================================
// MODULE 6: Amyloid Processing
// ============================================================================

export const module6Edges: MechanisticEdge[] = [
  {
    id: 'E06.001',
    source: 'BACE1',
    target: 'APP_betaCTF',
    relation: 'directlyIncreases',
    moduleId: 'M06',
    mechanismLabel: 'BACE1_APP_cleavage',
    mechanismDescription: 'BACE1 cleaves APP at β-site → releases sAPPβ and membrane-bound β-CTF (C99)',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Vassar',
        year: 1999,
        title: 'Beta-secretase cleavage of Alzheimer\'s amyloid precursor protein',
        pmid: '10531052',
        doi: '10.1126/science.286.5440.735',
        methodType: 'knockout',
        methodDetails: 'BACE1-/- eliminates Aβ production',
        causalConfidence: 'L3',
        species: { ncbiTaxon: 'NCBITaxon:10090', commonName: 'mouse' },
      },
    ],
    keyInsight: 'BACE1 is rate-limiting for Aβ production; validated therapeutic target',
  },
  {
    id: 'E06.002',
    source: 'APP_betaCTF',
    target: 'Abeta_monomers',
    relation: 'directlyIncreases',
    moduleId: 'M06',
    mechanismLabel: 'gamma_secretase_cleavage',
    mechanismDescription: 'γ-secretase cleaves β-CTF → releases Aβ peptides (Aβ40, Aβ42, Aβ43)',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'De Strooper',
        year: 1998,
        title: 'Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein',
        pmid: '9461215',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E06.003',
    source: 'Abeta_monomers',
    target: 'Abeta_oligomers',
    relation: 'increases',
    moduleId: 'M06',
    mechanismLabel: 'oligomerization',
    mechanismDescription: 'Aβ monomers aggregate into soluble oligomers (dimers, trimers, Aβ*56). Oligomers are the TOXIC species',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '16838177',
        doi: '10.1038/nature04533',
        firstAuthor: 'Lesne',
        year: 2006,
        title: 'A specific amyloid-β protein assembly in the brain impairs memory',
        quote: 'Aβ*56 impairs memory independently of plaques or neuronal loss',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
        species: { ncbiTaxon: 'NCBITaxon:10090', commonName: 'mouse', model: 'Tg2576' },
      },
    ],
    translationalGap: 'NOTE: Lesne 2006 has image manipulation concerns; oligomer toxicity supported by independent studies',
  },
  {
    id: 'E06.004',
    source: 'Abeta_oligomers',
    target: 'Abeta_plaques',
    relation: 'increases',
    moduleId: 'M06',
    mechanismLabel: 'plaque_deposition',
    mechanismDescription: 'Oligomers seed fibril formation → amyloid plaques. Plaques may be PROTECTIVE sequestration of toxic oligomers',
    causalConfidence: 'L4',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        title: 'Standard amyloid literature',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'Paradox: plaques correlate poorly with cognition; oligomers correlate better',
  },
  {
    id: 'E06.005',
    source: 'Abeta_oligomers',
    target: 'LTP_inhibition',
    relation: 'directlyIncreases',
    moduleId: 'M06',
    mechanismLabel: 'synaptic_toxicity',
    mechanismDescription: 'Aβ oligomers bind PrPc/mGluR5 → block LTP, enhance LTD → synaptic dysfunction',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '19029886',
        doi: '10.1038/nature07761',
        firstAuthor: 'Lauren',
        year: 2009,
        title: 'Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E06.006',
    source: 'phagocytosis_impaired',
    target: 'Abeta_oligomers',
    relation: 'increases',
    moduleId: 'M06',
    mechanismLabel: 'clearance_failure',
    mechanismDescription: 'Impaired microglial phagocytosis (from LDAM phenotype) → reduced Aβ clearance → oligomers accumulate',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 5 (LDAM)',
    evidence: [
      {
        pmid: '31959936',
        firstAuthor: 'Marschallinger',
        year: 2020,
        title: 'Lipid-droplet-accumulating microglia...',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E06.007',
    source: 'lysosomal_dysfunction',
    target: 'Abeta_monomers',
    relation: 'increases',
    moduleId: 'M06',
    mechanismLabel: 'PANTHOS_pathway',
    mechanismDescription: 'Lysosomal de-acidification → autolysosomes become Aβ production sites (PANTHOS). Aβ produced INSIDE neurons, not just secreted',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 2 (Lysosomal)',
    evidence: [
      {
        pmid: '35654956',
        doi: '10.1038/s41593-022-01084-8',
        firstAuthor: 'Lee',
        year: 2022,
        title: 'Faulty autolysosome acidification...induces autophagic build-up of Aβ in neurons, yielding senile plaques',
        quote: 'Build-up of Aβ/APP-βCTF selectively within enlarged de-acidified autolysosomes',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'PARADIGM SHIFT: Aβ is produced in dysfunctional autolysosomes, not just at plasma membrane',
  },
];

// ============================================================================
// MODULE 7: Tau Pathology & Transsulfuration
// ============================================================================

export const module7Edges: MechanisticEdge[] = [
  // 7A: Tau pathology
  {
    id: 'E07.001',
    source: 'tau_hyperphosphorylated',
    target: 'tau_misfolded',
    relation: 'increases',
    moduleId: 'M07',
    mechanismLabel: 'phospho_tau_conformational_change',
    mechanismDescription: 'Hyperphosphorylation promotes tau detachment from microtubules and conformational changes exposing aggregation-prone regions',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '26631930',
        doi: '10.1038/nrn.2015.1',
        firstAuthor: 'Wang',
        year: 2016,
        title: 'Tau in physiology and pathology',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E07.002',
    source: 'tau_misfolded',
    target: 'tau_aggregated',
    relation: 'increases',
    moduleId: 'M07',
    mechanismLabel: 'tau_aggregation',
    mechanismDescription: 'Misfolded tau forms paired helical filaments (PHF) → neurofibrillary tangles (NFT)',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '26631930',
        firstAuthor: 'Wang',
        year: 2016,
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E07.003',
    source: 'tau_aggregated',
    target: 'tau_seeding',
    relation: 'directlyIncreases',
    moduleId: 'M07',
    mechanismLabel: 'prion_like_spreading',
    mechanismDescription: 'Aggregated tau acts as seed, templating misfolding of normal tau in connected neurons',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '23898162',
        doi: '10.1016/j.cell.2013.07.033',
        firstAuthor: 'Sanders',
        year: 2014,
        title: 'Distinct tau prion strains propagate in cells and mice',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'Tau spreading follows neural connectivity (Braak staging)',
  },
  {
    id: 'E07.004',
    source: 'tau_aggregated',
    target: 'neuronal_dysfunction',
    relation: 'increases',
    moduleId: 'M07',
    mechanismLabel: 'tau_toxicity',
    mechanismDescription: 'Tau aggregates disrupt axonal transport, impair proteostasis, cause synaptic dysfunction',
    causalConfidence: 'L4',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  // 7B: Transsulfuration pathway (CSE/H2S)
  {
    id: 'E07.005',
    source: 'CSE',
    target: 'H2S',
    relation: 'directlyIncreases',
    moduleId: 'M07',
    mechanismLabel: 'H2S_production',
    mechanismDescription: 'CSE catalyzes cysteine → H₂S + pyruvate. CSE is the primary H₂S synthase in brain',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '19027017',
        firstAuthor: 'Abe',
        year: 2008,
        title: 'The possible role of hydrogen sulfide as an endogenous neuromodulator',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E07.006',
    source: 'H2S',
    target: 'GSK3B_active',
    relation: 'decreases',
    moduleId: 'M07',
    mechanismLabel: 'H2S_GSK3B_sulfhydration',
    mechanismDescription: 'H₂S sulfhydrates GSK3β at Cys218 → inhibits kinase activity → reduces tau phosphorylation',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '25065588',
        doi: '10.1016/j.bbamcr.2014.07.003',
        firstAuthor: 'Giovinazzo',
        year: 2014,
        title: 'Hydrogen sulfide is neuroprotective in Alzheimer\'s disease by sulfhydrating GSK3β and inhibiting tau hyperphosphorylation',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'CSE loss → ↓H₂S → GSK3β hyperactive → tau pathology',
  },
  {
    id: 'E07.007',
    source: 'CSE',
    target: 'GSH',
    relation: 'increases',
    moduleId: 'M07',
    mechanismLabel: 'cysteine_GSH_synthesis',
    mechanismDescription: 'CSE provides cysteine via transsulfuration; cysteine is rate-limiting for glutathione (GSH) synthesis',
    causalConfidence: 'L5',
    crossModule: 'Output to Module 9 (Ferroptosis - GPX4 requires GSH)',
    evidence: [
      {
        firstAuthor: 'Sbodio',
        year: 2019,
        pmid: '30455430',
        title: 'Regulators of the transsulfuration pathway',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
    keyInsight: 'Links transsulfuration to ferroptosis protection',
  },
  {
    id: 'E07.008',
    source: 'aging',
    target: 'CSE',
    relation: 'decreases',
    moduleId: 'M07',
    mechanismLabel: 'age_CSE_decline',
    mechanismDescription: 'CSE expression/activity declines with age → H₂S and cysteine depletion',
    causalConfidence: 'L6',
    evidence: [
      {
        pmid: '39420891',
        doi: '10.1073/pnas.2528478122',
        firstAuthor: 'Chakraborty',
        year: 2025,
        title: 'The transsulfuration pathway metabolite hydrogen sulfide regulates brain iron metabolism',
        methodType: 'cohort',
        causalConfidence: 'L6',
      },
    ],
  },
];

// ============================================================================
// MODULE 8: Complement-Mediated Synapse Elimination
// ============================================================================

export const module8Edges: MechanisticEdge[] = [
  {
    id: 'E08.001',
    source: 'aging',
    target: 'C1q',
    relation: 'increases',
    moduleId: 'M08',
    mechanismLabel: 'age_C1q_upregulation',
    mechanismDescription: 'C1q increases ~300-fold in aged brain (primarily from microglia). Reactivation of developmental pruning pathway',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '23946404',
        doi: '10.1523/JNEUROSCI.1333-13.2013',
        firstAuthor: 'Stephan',
        year: 2013,
        title: 'A dramatic increase of C1q protein in the CNS during normal aging',
        quote: 'C1q is increased up to 300-fold in some regions of the aged mouse and human brain',
        methodType: 'cohort',
        causalConfidence: 'L6',
        species: { ncbiTaxon: 'NCBITaxon:9606', commonName: 'human' },
      },
    ],
    keyInsight: 'LANDMARK: C1q upregulation is universal feature of brain aging',
  },
  {
    id: 'E08.002',
    source: 'C1q',
    target: 'C3',
    relation: 'directlyIncreases',
    moduleId: 'M08',
    mechanismLabel: 'complement_cascade_initiation',
    mechanismDescription: 'C1q binds synapses → activates C1r/C1s → cleaves C4 → cleaves C2 → cleaves C3 → deposits iC3b',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '18083105',
        doi: '10.1016/j.cell.2007.10.036',
        firstAuthor: 'Stevens',
        year: 2007,
        title: 'The classical complement cascade mediates CNS synapse elimination',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'DISCOVERY: Complement cascade mediates developmental synapse elimination (Stevens 2007)',
  },
  {
    id: 'E08.003',
    source: 'C3',
    target: 'CR3_microglia',
    relation: 'increases',
    moduleId: 'M08',
    mechanismLabel: 'C3_iC3b_opsonization',
    mechanismDescription: 'C3 cleavage deposits iC3b on synapses → recognized by microglial CR3 (CD11b/CD18)',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '22632727',
        doi: '10.1016/j.neuron.2012.03.026',
        firstAuthor: 'Schafer',
        year: 2012,
        title: 'Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner',
        quote: 'CR3, the receptor for complement component C3, is required for microglia-mediated synapse elimination',
        methodType: 'knockout',
        methodDetails: 'CR3-/- mice have impaired synapse elimination',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E08.004',
    source: 'CR3_microglia',
    target: 'synapse_engulfment',
    relation: 'directlyIncreases',
    moduleId: 'M08',
    mechanismLabel: 'CR3_phagocytosis_trigger',
    mechanismDescription: 'CR3 binding to iC3b-tagged synapses triggers microglial phagocytosis → synapse elimination',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '22632727',
        firstAuthor: 'Schafer',
        year: 2012,
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E08.005',
    source: 'synapse_engulfment',
    target: 'synapses',
    relation: 'decreases',
    moduleId: 'M08',
    mechanismLabel: 'synapse_loss',
    mechanismDescription: 'Excessive synapse engulfment → synapse loss → circuit dysfunction',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '27033548',
        doi: '10.1126/science.aad8373',
        firstAuthor: 'Hong',
        year: 2016,
        title: 'Complement and microglia mediate early synapse loss in Alzheimer mouse models',
        quote: 'Inhibition of C1q, C3, or the microglial complement receptor CR3 reduces the number of phagocytic microglia, as well as the extent of early synapse loss',
        methodType: 'knockout',
        methodDetails: 'C1q-/-, C3-/-, CR3-/- all prevent synapse loss',
        causalConfidence: 'L3',
        species: { ncbiTaxon: 'NCBITaxon:10090', commonName: 'mouse', model: 'J20 APP' },
      },
    ],
    keyInsight: 'LANDMARK: Complement-mediated synapse loss occurs BEFORE plaques (Hong 2016)',
  },
  {
    id: 'E08.006',
    source: 'synapses',
    target: 'cognitive_score',
    relation: 'increases',
    moduleId: 'M08',
    mechanismLabel: 'synapse_cognition_correlation',
    mechanismDescription: 'Synapse density is STRONGEST anatomical correlate of cognitive function - better than plaques or tangles',
    causalConfidence: 'L6',
    evidence: [
      {
        pmid: '23946404',
        firstAuthor: 'Stephan',
        year: 2013,
        quote: 'aged C1q-deficient mice exhibited significantly less cognitive and memory decline',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'C1q-/- mice protected from age-related cognitive decline',
  },
  {
    id: 'E08.007',
    source: 'Abeta_oligomers',
    target: 'C1q',
    relation: 'increases',
    moduleId: 'M08',
    mechanismLabel: 'Abeta_C1q_induction',
    mechanismDescription: 'Aβ oligomers induce C1q expression/deposition on synapses',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 6 (Amyloid)',
    evidence: [
      {
        pmid: '27033548',
        firstAuthor: 'Hong',
        year: 2016,
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
];

// ============================================================================
// MODULE 9: Iron Dysregulation & Ferroptosis
// ============================================================================

export const module9Edges: MechanisticEdge[] = [
  {
    id: 'E09.001',
    source: 'IL1B',
    target: 'hepcidin',
    relation: 'increases',
    moduleId: 'M09',
    mechanismLabel: 'IL6_STAT3_hepcidin',
    mechanismDescription: 'IL-6/IL-1β → JAK2 → STAT3 → HAMP promoter → hepcidin transcription. Links neuroinflammation to iron maldistribution',
    causalConfidence: 'L4',
    crossModule: 'Input from Module 4 (Inflammation)',
    evidence: [
      {
        pmid: '17148587',
        doi: '10.1182/blood-2006-06-027631',
        firstAuthor: 'Nemeth',
        year: 2006,
        title: 'IL-6 mediates hypoferremia of inflammation',
        methodType: 'intervention_human',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E09.002',
    source: 'hepcidin',
    target: 'ferroportin',
    relation: 'decreases',
    moduleId: 'M09',
    mechanismLabel: 'hepcidin_ferroportin_degradation',
    mechanismDescription: 'Hepcidin binds ferroportin → internalization → ubiquitination → degradation. Ferroportin is ONLY cellular iron exporter',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '15514116',
        doi: '10.1126/science.1104742',
        firstAuthor: 'Nemeth',
        year: 2004,
        title: 'Hepcidin regulates cellular iron efflux',
        quote: 'Hepcidin binds to ferroportin, induces its internalization and degradation',
        methodType: 'in_vitro',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'Master regulatory edge for iron distribution',
  },
  {
    id: 'E09.003',
    source: 'ferroportin',
    target: 'labile_iron',
    relation: 'decreases',
    moduleId: 'M09',
    mechanismLabel: 'ferroportin_iron_export',
    mechanismDescription: 'Ferroportin exports Fe²⁺ from cells. When degraded, iron accumulates intracellularly',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '15514116',
        firstAuthor: 'Nemeth',
        year: 2004,
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E09.004',
    source: 'labile_iron',
    target: 'lipid_peroxides',
    relation: 'directlyIncreases',
    moduleId: 'M09',
    mechanismLabel: 'Fenton_reaction',
    mechanismDescription: 'Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻ (Fenton reaction). Hydroxyl radicals attack membrane PUFA → lipid peroxides',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '22632970',
        doi: '10.1016/j.cell.2012.03.042',
        firstAuthor: 'Dixon',
        year: 2012,
        title: 'Ferroptosis: an iron-dependent form of nonapoptotic cell death',
        quote: 'Iron chelators blocked ferroptosis, indicating iron is required',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'DISCOVERY paper for ferroptosis (Dixon 2012)',
  },
  {
    id: 'E09.005',
    source: 'GPX4',
    target: 'lipid_peroxides',
    relation: 'decreases',
    moduleId: 'M09',
    mechanismLabel: 'GPX4_lipid_peroxide_reduction',
    mechanismDescription: 'GPX4 reduces lipid peroxides (LOOH → LOH) using GSH. GPX4 is the ONLY enzyme that detoxifies membrane lipid peroxides',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '24439385',
        doi: '10.1038/ncb2897',
        firstAuthor: 'Yang',
        year: 2014,
        title: 'Regulation of ferroptotic cancer cell death by GPX4',
        quote: 'GPX4 is the critical regulator of ferroptotic cancer cell death',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'GPX4 is MASTER ferroptosis brake; requires GSH (CSE-dependent)',
  },
  {
    id: 'E09.006',
    source: 'lipid_peroxides',
    target: 'ferroptosis',
    relation: 'directlyIncreases',
    moduleId: 'M09',
    mechanismLabel: 'lipid_peroxide_ferroptosis',
    mechanismDescription: 'Accumulated lipid peroxides → membrane rupture → ferroptotic cell death',
    causalConfidence: 'L5',
    evidence: [
      {
        pmid: '22632970',
        firstAuthor: 'Dixon',
        year: 2012,
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E09.007',
    source: 'GSH',
    target: 'GPX4',
    relation: 'increases',
    moduleId: 'M09',
    mechanismLabel: 'GSH_GPX4_cofactor',
    mechanismDescription: 'GSH is essential cofactor for GPX4. GSH depletion → GPX4 inactive → ferroptosis',
    causalConfidence: 'L5',
    crossModule: 'Input from Module 7B (CSE provides cysteine for GSH)',
    evidence: [
      {
        firstAuthor: 'Costa',
        year: 2023,
        pmid: '36894028',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E09.008',
    source: 'senescent_cells',
    target: 'SASP',
    relation: 'increases',
    moduleId: 'M09',
    mechanismLabel: 'iron_driven_SASP',
    mechanismDescription: 'Iron-loaded senescent cells produce SASP factors. Iron accumulation DRIVES SASP',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '38036770',
        doi: '10.1038/s42255-023-00928-2',
        firstAuthor: 'Maus',
        year: 2023,
        title: 'Iron accumulation drives fibrosis, senescence and the SASP',
        quote: 'Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'Targeted ferroptosis in senescent cells is therapeutic strategy',
  },
];

// ============================================================================
// MODULE 10: APOE4 & REST
// ============================================================================

export const module10Edges: MechanisticEdge[] = [
  {
    id: 'E10.001',
    source: 'APOE4_genotype',
    target: 'APOE4_domain_interaction',
    relation: 'directlyIncreases',
    moduleId: 'M10',
    mechanismLabel: 'APOE4_structural_defect',
    mechanismDescription: 'APOE4 Arg112 causes domain interaction between N- and C-terminus → unstable, poorly lipidated',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Mahley',
        year: 2006,
        pmid: '16945100',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E10.002',
    source: 'APOE4_domain_interaction',
    target: 'APOE_lipidation_impaired',
    relation: 'increases',
    moduleId: 'M10',
    mechanismLabel: 'domain_interaction_lipidation',
    mechanismDescription: 'Domain interaction impairs ABCA1-mediated lipidation → hypolipidated APOE4',
    causalConfidence: 'L4',
    evidence: [
      {
        firstAuthor: 'Mahley',
        year: 2006,
        pmid: '16945100',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E10.003',
    source: 'APOE_lipidation_impaired',
    target: 'Abeta_clearance_reduced',
    relation: 'increases',
    moduleId: 'M10',
    mechanismLabel: 'APOE4_Abeta_clearance',
    mechanismDescription: 'Hypolipidated APOE4 is less effective at Aβ clearance via LRP1 and BBB transport',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 6 (Amyloid)',
    evidence: [
      {
        firstAuthor: 'Castellano',
        year: 2011,
        pmid: '21725313',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E10.004',
    source: 'aging',
    target: 'REST_nuclear',
    relation: 'decreases',
    moduleId: 'M10',
    mechanismLabel: 'age_REST_depletion',
    mechanismDescription: 'REST nuclear localization declines with age in vulnerable neurons',
    causalConfidence: 'L6',
    evidence: [
      {
        pmid: '25599404',
        doi: '10.1038/nature14100',
        firstAuthor: 'Lu',
        year: 2014,
        title: 'REST and stress resistance in ageing and Alzheimer\'s disease',
        quote: 'REST is lost from the nucleus in ageing cortical and hippocampal neurons',
        methodType: 'cohort',
        causalConfidence: 'L6',
        species: { ncbiTaxon: 'NCBITaxon:9606', commonName: 'human' },
      },
    ],
    keyInsight: 'LANDMARK: REST nuclear loss correlates with AD vulnerability',
  },
  {
    id: 'E10.005',
    source: 'REST_nuclear',
    target: 'Nrf2_activity',
    relation: 'increases',
    moduleId: 'M10',
    mechanismLabel: 'REST_Nrf2_coordination',
    mechanismDescription: 'REST coordinates with Nrf2 in stress resistance program',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '25599404',
        firstAuthor: 'Lu',
        year: 2014,
        methodType: 'cohort',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E10.006',
    source: 'Nrf2_activity',
    target: 'GPX4',
    relation: 'increases',
    moduleId: 'M10',
    mechanismLabel: 'Nrf2_GPX4_induction',
    mechanismDescription: 'Nrf2 induces GPX4 and other ferroptosis-protective genes',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 9 (Ferroptosis)',
    evidence: [
      {
        pmid: '35342364',
        firstAuthor: 'Wang',
        year: 2022,
        quote: 'the Nrf2/GPX4 axis played a key role in these effects',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
];

// ============================================================================
// MODULE 11: TREM2 & DAM
// ============================================================================

export const module11Edges: MechanisticEdge[] = [
  {
    id: 'E11.001',
    source: 'TREM2_surface',
    target: 'DAM_stage1',
    relation: 'increases',
    moduleId: 'M11',
    mechanismLabel: 'TREM2_DAM_transition',
    mechanismDescription: 'TREM2 signaling required for transition from homeostatic to DAM phenotype',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28602351',
        doi: '10.1016/j.cell.2017.05.018',
        firstAuthor: 'Keren-Shaul',
        year: 2017,
        title: 'A unique microglia type associated with restricting development of Alzheimer\'s disease',
        quote: 'TREM2 signaling is required for the transition from the first to the second stage of DAM',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'LANDMARK: Discovery of DAM phenotype (Keren-Shaul 2017)',
  },
  {
    id: 'E11.002',
    source: 'DAM_stage1',
    target: 'DAM_stage2',
    relation: 'increases',
    moduleId: 'M11',
    mechanismLabel: 'DAM_progression',
    mechanismDescription: 'Stage 1 DAM → Stage 2 DAM requires TREM2 signaling',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '28602351',
        firstAuthor: 'Keren-Shaul',
        year: 2017,
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
  },
  {
    id: 'E11.003',
    source: 'DAM_stage2',
    target: 'plaque_barrier',
    relation: 'increases',
    moduleId: 'M11',
    mechanismLabel: 'DAM_plaque_compaction',
    mechanismDescription: 'DAM microglia form protective barrier around plaques, compacting them to reduce toxicity',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '29518356',
        doi: '10.1016/j.neuron.2018.02.016',
        firstAuthor: 'Yuan',
        year: 2018,
        title: 'TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function',
        methodType: 'knockout',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E11.004',
    source: 'TREM2_variants',
    target: 'TREM2_surface',
    relation: 'decreases',
    moduleId: 'M11',
    mechanismLabel: 'TREM2_variant_hypomorph',
    mechanismDescription: 'R47H and other AD-risk variants reduce TREM2 surface expression/signaling',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '23150934',
        doi: '10.1056/NEJMoa1211851',
        firstAuthor: 'Jonsson',
        year: 2013,
        title: 'Variant of TREM2 associated with the risk of Alzheimer\'s disease',
        methodType: 'cohort',
        causalConfidence: 'L6',
      },
    ],
  },
  {
    id: 'E11.005',
    source: 'TREM2_surface',
    target: 'sTREM2',
    relation: 'increases',
    moduleId: 'M11',
    mechanismLabel: 'TREM2_shedding',
    mechanismDescription: 'ADAM10/17 cleave TREM2 ectodomain → soluble TREM2 (sTREM2) in CSF',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Schlepckow',
        year: 2017,
        pmid: '28885578',
        methodType: 'in_vitro',
        causalConfidence: 'L5',
      },
    ],
    keyInsight: 'sTREM2 is CSF biomarker for microglial activation',
  },
];

// ============================================================================
// MODULE 12: BBB & Glymphatic System
// ============================================================================

export const module12Edges: MechanisticEdge[] = [
  {
    id: 'E12.001',
    source: 'APOE4_genotype',
    target: 'CypA_BBB',
    relation: 'increases',
    moduleId: 'M12',
    mechanismLabel: 'APOE4_CypA_upregulation',
    mechanismDescription: 'APOE4 fails to suppress CypA in pericytes → CypA accumulates → MMP9 activation → BBB breakdown',
    causalConfidence: 'L3',
    evidence: [
      {
        pmid: '22696567',
        doi: '10.1038/nature11087',
        firstAuthor: 'Bell',
        year: 2012,
        title: 'Apolipoprotein E controls cerebrovascular integrity via cyclophilin A',
        quote: 'ApoE4 activates a CypA-MMP9 pathway in pericytes leading to blood-brain barrier degradation',
        methodType: 'knockout',
        causalConfidence: 'L3',
      },
    ],
    keyInsight: 'LANDMARK: APOE4-specific BBB vulnerability pathway',
  },
  {
    id: 'E12.002',
    source: 'CypA_BBB',
    target: 'MMP9_BBB',
    relation: 'directlyIncreases',
    moduleId: 'M12',
    mechanismLabel: 'CypA_MMP9_activation',
    mechanismDescription: 'CypA → NF-κB → MMP9 transcription and activation',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '22696567',
        firstAuthor: 'Bell',
        year: 2012,
        methodType: 'knockout',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E12.003',
    source: 'MMP9_BBB',
    target: 'BBB_breakdown',
    relation: 'directlyIncreases',
    moduleId: 'M12',
    mechanismLabel: 'MMP9_tight_junction_degradation',
    mechanismDescription: 'MMP9 degrades basement membrane and tight junction proteins → BBB leakage',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '22696567',
        firstAuthor: 'Bell',
        year: 2012,
        methodType: 'knockout',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E12.004',
    source: 'sleep_disruption',
    target: 'glymphatic_clearance',
    relation: 'decreases',
    moduleId: 'M12',
    mechanismLabel: 'sleep_glymphatic',
    mechanismDescription: 'Glymphatic clearance is 60% higher during sleep. Sleep disruption impairs Aβ clearance',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '24136970',
        doi: '10.1126/science.1241224',
        firstAuthor: 'Xie',
        year: 2013,
        title: 'Sleep drives metabolite clearance from the adult brain',
        quote: 'Natural sleep or anesthesia are associated with a 60% increase in the interstitial space',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'LANDMARK: Sleep-glymphatic-Aβ clearance connection',
  },
  {
    id: 'E12.005',
    source: 'glymphatic_clearance',
    target: 'Abeta_oligomers',
    relation: 'decreases',
    moduleId: 'M12',
    mechanismLabel: 'glymphatic_Abeta_clearance',
    mechanismDescription: 'Glymphatic system clears Aβ and other waste; impairment → Aβ accumulation',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 6 (Amyloid)',
    evidence: [
      {
        pmid: '24136970',
        firstAuthor: 'Xie',
        year: 2013,
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E12.006',
    source: 'aging',
    target: 'glymphatic_clearance',
    relation: 'decreases',
    moduleId: 'M12',
    mechanismLabel: 'age_glymphatic_decline',
    mechanismDescription: 'Glymphatic function declines 80-90% with age (AQP4 redistribution, arterial stiffening)',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '25190365',
        doi: '10.1002/ana.24271',
        firstAuthor: 'Kress',
        year: 2014,
        title: 'Impairment of paravascular clearance pathways in the aging brain',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
  },
];

// ============================================================================
// MODULE 13: Cholinergic Dysfunction
// ============================================================================

export const module13Edges: MechanisticEdge[] = [
  {
    id: 'E13.001',
    source: 'tau_aggregated',
    target: 'cholinergic_degeneration',
    relation: 'increases',
    moduleId: 'M13',
    mechanismLabel: 'tau_nbM_vulnerability',
    mechanismDescription: 'Basal forebrain cholinergic neurons (nbM) are selectively vulnerable to tau pathology',
    causalConfidence: 'L6',
    crossModule: 'Input from Module 7 (Tau)',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'cohort',
        causalConfidence: 'L6',
      },
    ],
  },
  {
    id: 'E13.002',
    source: 'cholinergic_degeneration',
    target: 'ACh_reduced',
    relation: 'increases',
    moduleId: 'M13',
    mechanismLabel: 'cholinergic_loss_ACh',
    mechanismDescription: 'Loss of cholinergic neurons → reduced ACh synthesis and release',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 1980,
        title: 'Foundational cholinergic hypothesis literature',
        methodType: 'cohort',
        causalConfidence: 'L6',
      },
    ],
  },
  {
    id: 'E13.003',
    source: 'ACh_reduced',
    target: 'cognitive_score',
    relation: 'increases',
    moduleId: 'M13',
    mechanismLabel: 'ACh_cognition',
    mechanismDescription: 'ACh is essential for attention, learning, memory. Basis for AChEI therapy',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 1990,
        methodType: 'rct',
        causalConfidence: 'L2',
      },
    ],
    keyInsight: 'AChEIs (donepezil, rivastigmine) provide symptomatic benefit',
  },
];

// ============================================================================
// MODULE 14: MAM & Calcium
// ============================================================================

export const module14Edges: MechanisticEdge[] = [
  {
    id: 'E14.001',
    source: 'familial_AD_mutations',
    target: 'MAM_hyperconnectivity',
    relation: 'increases',
    moduleId: 'M14',
    mechanismLabel: 'PS_MAM_upregulation',
    mechanismDescription: 'PS1/PS2 mutations increase ER-mitochondria contacts (MAM) → enhanced Ca²⁺ transfer',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '22334919',
        doi: '10.1083/jcb.201108170',
        firstAuthor: 'Area-Gomez',
        year: 2012,
        title: 'Upregulated function of mitochondria-associated ER membranes in Alzheimer disease',
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'LANDMARK: MAM hypothesis of AD (Area-Gomez)',
  },
  {
    id: 'E14.002',
    source: 'MAM_hyperconnectivity',
    target: 'ER_mito_Ca_flux',
    relation: 'increases',
    moduleId: 'M14',
    mechanismLabel: 'MAM_Ca_transfer',
    mechanismDescription: 'MAM hyperconnectivity → excessive Ca²⁺ transfer from ER to mitochondria via IP3R-VDAC-MCU',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '22334919',
        firstAuthor: 'Area-Gomez',
        year: 2012,
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E14.003',
    source: 'ER_mito_Ca_flux',
    target: 'Ca_overload',
    relation: 'increases',
    moduleId: 'M14',
    mechanismLabel: 'MAM_mito_Ca_overload',
    mechanismDescription: 'Excessive Ca²⁺ transfer → mitochondrial Ca²⁺ overload → mPTP opening',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 3 (Mitochondrial)',
    evidence: [
      {
        pmid: '22334919',
        firstAuthor: 'Area-Gomez',
        year: 2012,
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
  {
    id: 'E14.004',
    source: 'MAM_hyperconnectivity',
    target: 'gamma_secretase_MAM',
    relation: 'increases',
    moduleId: 'M14',
    mechanismLabel: 'MAM_gamma_secretase',
    mechanismDescription: 'γ-secretase is enriched at MAM; MAM expansion increases Aβ production',
    causalConfidence: 'L4',
    crossModule: 'Output to Module 6 (Amyloid)',
    evidence: [
      {
        pmid: '22334919',
        firstAuthor: 'Area-Gomez',
        year: 2012,
        methodType: 'in_vitro',
        causalConfidence: 'L4',
      },
    ],
  },
];

// ============================================================================
// MODULE 15: Interventions Framework
// ============================================================================

export const module15Edges: MechanisticEdge[] = [
  {
    id: 'E15.001',
    source: 'drug_intervention',
    target: 'BBB_penetration',
    relation: 'regulates',
    moduleId: 'M15',
    mechanismLabel: 'drug_BBB_challenge',
    mechanismDescription: 'Drug efficacy depends on BBB penetration. Many promising compounds fail due to poor CNS access',
    causalConfidence: 'L6',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'cohort',
        causalConfidence: 'L6',
      },
    ],
    keyInsight: 'BBB is major barrier for AD therapeutics',
  },
  {
    id: 'E15.002',
    source: 'BBB_penetration',
    target: 'target_engagement',
    relation: 'increases',
    moduleId: 'M15',
    mechanismLabel: 'CNS_target_engagement',
    mechanismDescription: 'CNS exposure required for target engagement. Must verify with PET or CSF biomarkers',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'rct',
        causalConfidence: 'L2',
      },
    ],
  },
  {
    id: 'E15.003',
    source: 'lifestyle_intervention',
    target: 'multiple_pathways',
    relation: 'regulates',
    moduleId: 'M15',
    mechanismLabel: 'lifestyle_pleiotropy',
    mechanismDescription: 'Exercise, diet, sleep, cognitive engagement affect multiple pathways simultaneously',
    causalConfidence: 'L4',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'rct',
        causalConfidence: 'L2',
      },
    ],
    keyInsight: 'Lifestyle interventions may succeed where single-target drugs fail',
  },
];

// ============================================================================
// MODULE 16: Sex & Ancestry Effects
// ============================================================================

export const module16Edges: MechanisticEdge[] = [
  {
    id: 'E16.001',
    source: 'sex',
    target: 'estrogen_levels',
    relation: 'regulates',
    moduleId: 'M16',
    mechanismLabel: 'sex_estrogen',
    mechanismDescription: 'Biological sex determines baseline estrogen levels; menopause causes precipitous decline in women',
    causalConfidence: 'L5',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'cohort',
        causalConfidence: 'L5',
      },
    ],
  },
  {
    id: 'E16.002',
    source: 'estrogen_levels',
    target: 'neuroprotection',
    relation: 'increases',
    moduleId: 'M16',
    mechanismLabel: 'estrogen_neuroprotection',
    mechanismDescription: 'Estrogen provides neuroprotection via anti-inflammatory, antioxidant, neurotrophic effects',
    causalConfidence: 'L4',
    evidence: [
      {
        firstAuthor: 'Various',
        year: 2020,
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'May explain 2:1 female:male AD prevalence',
  },
  {
    id: 'E16.003',
    source: 'FSH_elevated',
    target: 'neurodegeneration',
    relation: 'increases',
    moduleId: 'M16',
    mechanismLabel: 'FSH_neurodegeneration',
    mechanismDescription: 'Elevated FSH (post-menopausal) may directly contribute to neurodegeneration via C/EBPβ-δ-secretase pathway',
    causalConfidence: 'L4',
    evidence: [
      {
        pmid: '35995993',
        doi: '10.1038/s41586-022-05152-w',
        firstAuthor: 'Xiong',
        year: 2022,
        title: 'FSH blockade improves cognition in mice with Alzheimer\'s disease',
        methodType: 'intervention_animal',
        causalConfidence: 'L4',
      },
    ],
    keyInsight: 'FSH blockade is potential therapeutic target for women',
  },
  {
    id: 'E16.004',
    source: 'ancestry',
    target: 'APOE4_risk',
    relation: 'regulates',
    moduleId: 'M16',
    mechanismLabel: 'ancestry_APOE4_interaction',
    mechanismDescription: 'APOE4 risk varies by ancestry: highest in Japanese, intermediate in European, lower in African/Hispanic',
    causalConfidence: 'L6',
    evidence: [
      {
        pmid: '31648214',
        doi: '10.1001/jama.2019.16198',
        firstAuthor: 'Belloy',
        year: 2019,
        title: 'A Quarter Century of APOE and Alzheimer\'s Disease',
        methodType: 'meta_analysis',
        causalConfidence: 'L6',
      },
    ],
    keyInsight: 'Genetic background modifies APOE4 penetrance',
  },
];

// ============================================================================
// EXPORT ALL EDGES
// ============================================================================

export const allEdges: MechanisticEdge[] = [
  ...module1Edges,
  ...module2Edges,
  ...module3Edges,
  ...module4Edges,
  ...module5Edges,
  ...module6Edges,
  ...module7Edges,
  ...module8Edges,
  ...module9Edges,
  ...module10Edges,
  ...module11Edges,
  ...module12Edges,
  ...module13Edges,
  ...module14Edges,
  ...module15Edges,
  ...module16Edges,
];

export default allEdges;
